These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 1846441

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
    Vaupel DB, Cone EJ, Johnson RE, Su TP.
    J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
    [Abstract] [Full Text] [Related]

  • 43. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
    Baumhaker Y, Gafni M, Keren O, Sarne Y.
    Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
    [Abstract] [Full Text] [Related]

  • 44. Induction of Fos-like immunoreactivity by opioids in guinea-pig brain.
    Bot G, Chahl LA.
    Brain Res; 1996 Aug 26; 731(1-2):45-56. PubMed ID: 8883853
    [Abstract] [Full Text] [Related]

  • 45. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats.
    Przewłocka B, Lasoń W, Machelska H, van Luijtelaar G, Coenen A, Przewłocki R.
    Neurosci Lett; 1995 Feb 17; 186(2-3):131-4. PubMed ID: 7777181
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY, Seyed-Mozaffari A, Archer S, Bidlack JM.
    J Pharmacol Exp Ther; 1996 Nov 17; 279(2):539-47. PubMed ID: 8930155
    [Abstract] [Full Text] [Related]

  • 48. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M, Mizoguchi H, Narita M, Sora I, Uhl GR, Tseng LF.
    Br J Pharmacol; 1999 Jan 17; 126(2):451-6. PubMed ID: 10077238
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Characterization of the opioid receptor subtypes mediating the negative inotropic effects of DAMGO, DPDPE and U-50, 488H in isolated human right atria strips.
    Llobell F, Laorden ML.
    Neuropeptides; 1995 Aug 17; 29(2):115-9. PubMed ID: 7477762
    [Abstract] [Full Text] [Related]

  • 54. Opioid agonists modulate release of neurotransmitters in bovine trachealis muscle.
    Zappi L, Nicosia F, Rocchi D, Song P, Rehder K.
    Anesthesiology; 1995 Sep 17; 83(3):543-51. PubMed ID: 7661355
    [Abstract] [Full Text] [Related]

  • 55. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
    Garaulet JV, Laorden ML, Milanés MV.
    J Pharmacol Exp Ther; 1994 Jun 17; 269(3):993-9. PubMed ID: 8014886
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Opioid receptor subtypes in the supraoptic nucleus and posterior pituitary gland of morphine-tolerant rats.
    Sumner BE, Coombes JE, Pumford KM, Russell JA.
    Neuroscience; 1990 Jun 17; 37(3):635-45. PubMed ID: 2174133
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.